<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pharmaceutics-12-00688-t003" orientation="portrait" position="float">
 <object-id pub-id-type="pii">pharmaceutics-12-00688-t003_Table 3</object-id>
 <label>Table 3</label>
 <caption>
  <p>Anti-viral activity of SAAs.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SAA</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Viral Target </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Experimental Model</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">SDS/SLS (anionic surfactant)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Membrane disruption and capsid denaturation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV 1 and 2, HPV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">various cell lines</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B116-pharmaceutics-12-00688" ref-type="bibr">116</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Membrane disruption and capsid denaturation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV 1 and 2, HPV </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">various cell lines</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[
     <xref rid="B117-pharmaceutics-12-00688" ref-type="bibr">117</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV 2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vivo (hairless mice)</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SDS (anionic surfactant),levulinic acid and sodium hypochlorite</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Undefined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MNV, HAV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B129-pharmaceutics-12-00688" ref-type="bibr">129</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTAB (cationic surfactant),
     <break/>SDS (anionic surfactant)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Particle disassociation and entrapment in micelles</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MNV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vivo</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B130-pharmaceutics-12-00688" ref-type="bibr">130</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tween-20 (non-ionic surfactant),
     <break/>Triton X-100 (non-ionic surfactant) 
     <break/>NP-40 (non-ionic surfactant)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Capsid denaturation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MNV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAW 264.7 murine macrophages</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B128-pharmaceutics-12-00688" ref-type="bibr">128</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorhexidine (cationic surfactant)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Membrane disruption</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herpes virus</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hep-2 and RK
     <sub>13</sub> cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B118-pharmaceutics-12-00688" ref-type="bibr">118</xref>] 
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">African soap bars diluted in water</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Undefined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell-free HIV-1, HIV-1 infected lymphocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human PBMCs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B119-pharmaceutics-12-00688" ref-type="bibr">119</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common soaps</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Undefined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MNV-1, HuNoV GI.4 and GII.4</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vivo</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B134-pharmaceutics-12-00688" ref-type="bibr">134</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Micro-emulsion of Tween-80 (non-ionic surfactant and emulsifier), Span-20 (co-surfactant), ethanol, oil, isopropyl myristate (IPM), and distilled water</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Undefined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vero cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B120-pharmaceutics-12-00688" ref-type="bibr">120</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nano-emulsion ATB </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Undefined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell culture medium and surfaces</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vero cells </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B121-pharmaceutics-12-00688" ref-type="bibr">121</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nano-emulsion of soybean oil, tributyl phosphate AND Triton X-100 (non-ionic surfactant)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limited infectivity 
     <break/>in animals
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine influenza A virus</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vivo (CD-1 mice)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B125-pharmaceutics-12-00688" ref-type="bibr">125</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanoparticles coated with DDAB (cationic surfactant)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Structural damage and inactivation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H1N1 influenza strain</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDCK cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B124-pharmaceutics-12-00688" ref-type="bibr">124</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhamnolipid</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not defined</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV 1 and 2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDBK cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B135-pharmaceutics-12-00688" ref-type="bibr">135</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sophorolipid</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Membrane disruption</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cell-free HIV inactivation model</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B136-pharmaceutics-12-00688" ref-type="bibr">136</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>SLS: sodium lauryl sulfate; HIV: human immunodeficiency virus; HPV: human papilloma virus; HSV: herpes simplex virus; MNV: murine norovirus; HAV: hepatitis A virus; RK: rabbit kidney; HuNoV: human norovirus; DDAB: didodecyl dimethyl ammonium bromide; MDBK: Madin-Darby bovine kidney; PBMCs: peripheral blood mononuclear cells; MDCK: Madin–Darby canine kidney.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
